39th EDRN Steering Committee Meeting - EDRN Breast/GYN Collaborative Group Meeting

39th EDRN Steering Committee Meeting

---------------------

Breast and Gynecological Cancers Collaborative Group Meeting

Wednesday, November 9, 2022

1:30 p.m. – 5:00 p.m. Pacific

East Room

Agenda

Nominated Chair/Co-Chair:

 

NCI Program Directors:

All times are Pacific                                                                                                                                    
*presenting remotely

1:30 p.m. - 1:35 p.m. Welcome
o   Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute
o   Christos Patriotis, Ph.D., National Cancer Institute
1:35 p.m. – 1:45 p.m. Participation in EDRN Working Groups and Subcommittees
o   Technology and Resource Sharing Subcommittee


 Reference Set Working Group


o   Communication and Workshop Subcommittee
o   Prioritization Subcommittee
o   Collaboration and Publication Subcommittee
o   Data Sharing & Informatics Subcommittee
o   Standing Review Group (Reviews Associate Membership Applications--Membership Confidential)
1:45 p.m. – 2:45 p.m. Updates of Team/Collaborative Projects (Supported by Set-asides and Core Funds in previous EDRN cycle)
15 minute presentations/discussion
1:45 p.m. – 2:00 p.m. o  Falloposcopy - Visualization and Molecular Diagnosis of Ovarian Precursor Lesions and Occult Carcinomas
o  Jennifer Barton MD, PhD, University of Arizona
o  *Ie-Ming Shih, MD, PhD, Johns Hopkins University School of Medicine

2:00 p.m. – 2:15 p.m. tDNA Mutations and Methylation In Uterine Lavage and Cervical Swabs for Early Detection of Ovarian Cancer
o  Steven Skates, PhD, Massachusetts General Hospital
o  Charles Drescher, MD, Fred Hutchinson Cancer Center
2:15 p.m. – 2:30 p.m. Protein, Protein Complexes, and Autoantibody Biomarkers in Serum for the Early Detection of Ovarian Cancer
o  Robert Bast, MD, The University of Texas MD Anderson Cancer Center
o  Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute
o  Charles Drescher, MD, Fred Hutchinson Cancer Center
2:30 p.m. – 2:45 p.m. Imaging and Blood Biomarkers in Women with 4A, 4B Mammograms to Reduce Breast Biopsies
o  John Heine, PhD, H. Lee Moffitt Cancer Center and Research Institute, Inc.
o  *Jeffrey Marks, PhD, Duke University
2:45 p.m. – 2:55 p.m. Break
2:55 p.m. – 4:05 p.m. Clinical Utility Studies
2:55 p.m. – 3:05 p.m. Definition of Clinical Utility Trial
Moderators:
o   Steven Skates, PhD, Massachusetts General Hospital
o   *Jeffrey Marks, PhD, Duke University
3:05 p.m. – 3:25 p.m. Diagnostic Mammography Based on Data Fusion Modeling
o   *Jeffrey Marks, PhD, Duke University
o   John Heine, PhD, H. Lee Moffitt Cancer Center and Research Institute, Inc.
3:25 p.m. – 3:45 p.m. Multi-Cancer Early Detection (MCED) of Ovarian and Breast Cancers in Women at Increased Risk
o   Steven Skates, PhD, Massachusetts General Hospital
o   Abhijit Patel, MD, PhD, Yale University
3:45 p.m. – 4:05 p.m. Normal Risk Ovarian Cancer Screening Study (NROSS) 2
o   Robert Bast, MD, The University of Texas MD Anderson Cancer Center
o   Steven Skates, PhD, Massachusetts General Hospital
4:05 p.m. – 5:00 p.m. Intra-CCG and Inter-CCG Collaborative Studies in New EDRN Cycle
Moderators:
o   Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute
o   *Ie-Ming Shih, MD, PhD, Johns Hopkins University School of Medicine
5:00 p.m. Adjourn for the Day